A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)

A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT06012812 ·Status: COMPLETED ·Phase: PHASE2

Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis

NCT07054736 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

NCT05399368 ·Status: TERMINATED ·Phase: PHASE2

A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants

NCT07488065 ·Status: RECRUITING ·Phase: PHASE1

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

NCT06468956 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT07377838 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

NCT03824405 ·Status: COMPLETED ·Phase: PHASE2

Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis

NCT06026891 ·Status: RECRUITING ·Phase: PHASE3

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

NCT07239947 ·Status: RECRUITING ·Phase: PHASE1

A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT04162899 ·Status: COMPLETED ·Phase: PHASE2

Pharmacodynamic Blood Characteristics of ICP-332 in Patients With Moderate to Severe Atopic Dermatitis

NCT05702268 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

NCT04444752 ·Status: COMPLETED ·Phase: PHASE2

A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis

NCT07309055 ·Status: RECRUITING ·Phase: PHASE3

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03568318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects

NCT05409326 ·Status: UNKNOWN ·Phase: PHASE1

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

NCT04805411 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review

NCT06503536 ·Status: COMPLETED

A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

NCT07103174 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03661138 ·Status: COMPLETED ·Phase: PHASE3

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

NCT04975438 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

NCT05970432 ·Status: UNKNOWN ·Phase: PHASE2

A Phase Ⅲ Comparative Study of QL2108 to Dupixent®

NCT06884891 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis

NCT06931990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis

NCT06216392 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis

NCT06477835 ·Status: COMPLETED ·Phase: PHASE3